The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …

In late December 2019, several cases of pneumonia of unknown origin were reported from
China, which in early January 2020 were announced to be caused by a novel coronavirus …

Background & Aims Liver enzyme abnormalities are common in patients with coronavirus
disease 2019 (COVID-19). Whether or not severe acute respiratory syndrome coronavirus 2 …

Disclosures: SA Vardhana reported personal fees from Immunai and personal fees from
ADC Therapeutics outside the submitted work; in addition, SA Vardhana had a patent to …

There is currently an outbreak of pneumonia of unknown aetiology in Wuhan, China.
Although there are still several unanswered questions about this infection, we evaluate the …

In early December 2019 a cluster of cases of pneumonia of unknown cause was identified in
Wuhan, a city of 11 million persons in the People's Republic of China. Further investigation …

Confronting the challenge of the outbreak of COVID‐19 should sharpen our focus on global
drug access as a key issue in antiviral therapy testing. The testing and adoption of effective …

After the outbreak of the severe acute respiratory syndrome (SARS) in the world in 2003,
human coronaviruses (HCoVs) have been reported as pathogens that cause severe …

The infectious microscopic viruses invade living cells to reproduce themselves, and causes
chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to …

Abstract Coronavirus disease 2019 (COVID-19), a respiratory viral infection, has affected
more than 78 million individuals worldwide as of the end of December 2020. Previous …